Clinical trial Recruiting at 1 site Interventional Ages 11 to 18

Therapy to improve control and reduce symptoms in children with non-epileptic seizures

Official title: Retraining and Control Therapy (ReACT): Sense of Control and Catastrophic Symptom Expectations as Targets of a Cognitive Behavioral Treatment for Pediatric Psychogenic Non-epileptic Seizures (PNES) - R33 Phase

Run by University of Alabama at Birmingham · NCT06007053 · Data updated 2026-11-12

This study is testing a new therapy called ReACT to see if it can help children aged 11-18 with non-epileptic seizures feel more in control and reduce their symptoms.

More Convulsion, Non-Epileptic trials

Quick facts

Study typeInterventional
Ages11 Years to 18 Years
SexAll
Enrollment160 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedMarch 9, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 17, 2026
Trial IDNCT06007053 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 11-18 diagnosed with psychogenic non-epileptic seizures who have a supportive family member willing to participate.

Probably not a fit

Patients with comorbid epilepsy, severe intellectual disabilities, or severe mental illnesses may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Retraining and Control Therapy (ReACT) in treating pediatric patients aged 11-18 diagnosed with psychogenic non-epileptic seizures (PNES). Participants will be randomly assigned to either ReACT or supportive therapy, engaging in twelve sessions, with the first session conducted in-person and the remaining via telehealth. The study aims to measure changes in sense of control and catastrophic symptom expectations through various assessments, including pain tolerance and cortisol response. Data will be collected through questionnaires, PNES diaries, and physiological measures to assess treatment outcomes.

Why it matters

Potential benefit: If successful, this therapy could significantly improve the management of non-epileptic seizures in children by enhancing their sense of control and reducing anxiety related to symptoms.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in using behavioral therapies for managing non-epileptic seizures.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 11-18 years old.
* Diagnosis of psychogenic non-epileptic seizures by a medical doctor using video-EEG.
* Family member (parent/guardian if a minor) willing to participate and that the subject with PNES chooses.

Exclusion Criteria:

* Comorbid Epilepsy
* Less than 4 PNES per month
* Other paroxysmal nonepileptic events (e.g. episodes related to hypoxic-ischemic phenomena, sleep disorders or migraine-associated disorders)
* Participation in other therapy during the study
* Severe intellectual disability
* Severe mental illness (delusions/hallucinations)

Exclusion for CPT:

* Blood pressure \>130/80 mmHg for adolescents greater than or equal to 13 years old
* Either systolic and/or diastolic blood pressure greater than or equal to 95% based on sex and age for children less than 13 years old

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting

Study contacts

  • Principal investigator: Aaron Fobian, PhD — University of Alabama at Birmingham
  • Study coordinator: Aaron Fobian, PhD
  • Email: afobian@uabmc.edu
  • Phone: 205-934-2241

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.